333 related articles for article (PubMed ID: 19948164)
1. Glucocorticoids increase impairments in learning and memory due to elevated amyloid precursor protein expression and neuronal apoptosis in 12-month old mice.
Li WZ; Li WP; Yao YY; Zhang W; Yin YY; Wu GC; Gong HL
Eur J Pharmacol; 2010 Feb; 628(1-3):108-15. PubMed ID: 19948164
[TBL] [Abstract][Full Text] [Related]
2. Dexamethasone and Aβ₂₅-₃₅ accelerate learning and memory impairments due to elevate amyloid precursor protein expression and neuronal apoptosis in 12-month male rats.
Li WZ; Li WP; Huang DK; Kan HW; Wang X; Wu WY; Yin YY; Yao YY
Behav Brain Res; 2012 Feb; 227(1):142-9. PubMed ID: 22061800
[TBL] [Abstract][Full Text] [Related]
3. Protective effect of extract of Astragalus on learning and memory impairments and neurons' apoptosis induced by glucocorticoids in 12-month-old male mice.
Li WZ; Li WP; Zhang W; Yin YY; Sun XX; Zhou SS; Xu XQ; Tao CR
Anat Rec (Hoboken); 2011 Jun; 294(6):1003-14. PubMed ID: 21538932
[TBL] [Abstract][Full Text] [Related]
4. Trace amounts of copper induce neurotoxicity in the cholesterol-fed mice through apoptosis.
Lu J; Zheng YL; Wu DM; Sun DX; Shan Q; Fan SH
FEBS Lett; 2006 Dec; 580(28-29):6730-40. PubMed ID: 17134702
[TBL] [Abstract][Full Text] [Related]
5. Memory and learning impairment induced by dexamethasone in senescent but not young mice.
Yao YY; Liu DM; Xu DF; Li WP
Eur J Pharmacol; 2007 Nov; 574(1):20-8. PubMed ID: 17884039
[TBL] [Abstract][Full Text] [Related]
6. Protective effects of astragalosides on dexamethasone and Aβ25-35 induced learning and memory impairments due to decrease amyloid precursor protein expression in 12-month male rats.
Li WZ; Wu WY; Huang DK; Yin YY; Kan HW; Wang X; Yao YY; Li WP
Food Chem Toxicol; 2012 Jun; 50(6):1883-90. PubMed ID: 22484447
[TBL] [Abstract][Full Text] [Related]
7. Sublethal concentrations of prion peptide PrP106-126 or the amyloid beta peptide of Alzheimer's disease activates expression of proapoptotic markers in primary cortical neurons.
White AR; Guirguis R; Brazier MW; Jobling MF; Hill AF; Beyreuther K; Barrow CJ; Masters CL; Collins SJ; Cappai R
Neurobiol Dis; 2001 Apr; 8(2):299-316. PubMed ID: 11300725
[TBL] [Abstract][Full Text] [Related]
8. Chronic stress accelerates learning and memory impairments and increases amyloid deposition in APPV717I-CT100 transgenic mice, an Alzheimer's disease model.
Jeong YH; Park CH; Yoo J; Shin KY; Ahn SM; Kim HS; Lee SH; Emson PC; Suh YH
FASEB J; 2006 Apr; 20(6):729-31. PubMed ID: 16467370
[TBL] [Abstract][Full Text] [Related]
9. Beneficial effects of quetiapine in a transgenic mouse model of Alzheimer's disease.
He J; Luo H; Yan B; Yu Y; Wang H; Wei Z; Zhang Y; Xu H; Tempier A; Li X; Li XM
Neurobiol Aging; 2009 Aug; 30(8):1205-16. PubMed ID: 18079026
[TBL] [Abstract][Full Text] [Related]
10. Puerarin attenuates amyloid-beta-induced cognitive impairment through suppression of apoptosis in rat hippocampus in vivo.
Li J; Wang G; Liu J; Zhou L; Dong M; Wang R; Li X; Li X; Lin C; Niu Y
Eur J Pharmacol; 2010 Dec; 649(1-3):195-201. PubMed ID: 20868658
[TBL] [Abstract][Full Text] [Related]
11. Corticotropin-releasing hormone protects neurons against insults relevant to the pathogenesis of Alzheimer's disease.
Pedersen WA; McCullers D; Culmsee C; Haughey NJ; Herman JP; Mattson MP
Neurobiol Dis; 2001 Jun; 8(3):492-503. PubMed ID: 11442356
[TBL] [Abstract][Full Text] [Related]
12. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
Padmanabhan J; Levy M; Dickson DW; Potter H
Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
[TBL] [Abstract][Full Text] [Related]
13. Amyloid-beta(25-35)-induced memory impairments correlate with cell loss in rat hippocampus.
Stepanichev MY; Zdobnova IM; Zarubenko II; Moiseeva YV; Lazareva NA; Onufriev MV; Gulyaeva NV
Physiol Behav; 2004 Feb; 80(5):647-55. PubMed ID: 14984798
[TBL] [Abstract][Full Text] [Related]
14. Imipramine, in part through tumor necrosis factor alpha inhibition, prevents cognitive decline and beta-amyloid accumulation in a mouse model of Alzheimer's disease.
Chavant F; Deguil J; Pain S; Ingrand I; Milin S; Fauconneau B; Pérault-Pochat MC; Lafay-Chebassier C
J Pharmacol Exp Ther; 2010 Feb; 332(2):505-14. PubMed ID: 19889791
[TBL] [Abstract][Full Text] [Related]
15. Repeated novel cage exposure-induced improvement of early Alzheimer's-like cognitive and amyloid changes in TASTPM mice is unrelated to changes in brain endocannabinoids levels.
Pardon MC; Sarmad S; Rattray I; Bates TE; Scullion GA; Marsden CA; Barrett DA; Lowe J; Kendall DA
Neurobiol Aging; 2009 Jul; 30(7):1099-113. PubMed ID: 18023506
[TBL] [Abstract][Full Text] [Related]
16. Rac1 inhibition negatively regulates transcriptional activity of the amyloid precursor protein gene.
Wang PL; Niidome T; Akaike A; Kihara T; Sugimoto H
J Neurosci Res; 2009 Jul; 87(9):2105-14. PubMed ID: 19267423
[TBL] [Abstract][Full Text] [Related]
17. Mice knock out for the histone acetyltransferase p300/CREB binding protein-associated factor develop a resistance to amyloid toxicity.
Duclot F; Meffre J; Jacquet C; Gongora C; Maurice T
Neuroscience; 2010 May; 167(3):850-63. PubMed ID: 20219649
[TBL] [Abstract][Full Text] [Related]
18. Mutations in amyloid precursor protein and presenilin-1 genes increase the basal oxidative stress in murine neuronal cells and lead to increased sensitivity to oxidative stress mediated by amyloid beta-peptide (1-42), HO and kainic acid: implications for Alzheimer's disease.
Mohmmad Abdul H; Sultana R; Keller JN; St Clair DK; Markesbery WR; Butterfield DA
J Neurochem; 2006 Mar; 96(5):1322-35. PubMed ID: 16478525
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of gamma-secretase activity reduces Abeta production, reduces oxidative stress, increases mitochondrial activity and leads to reduced vulnerability to apoptosis: Implications for the treatment of Alzheimer's disease.
Sheng B; Gong K; Niu Y; Liu L; Yan Y; Lu G; Zhang L; Hu M; Zhao N; Zhang X; Tang P; Gong Y
Free Radic Biol Med; 2009 May; 46(10):1362-75. PubMed ID: 19264123
[TBL] [Abstract][Full Text] [Related]
20. Clioquinol decreases amyloid-beta burden and reduces working memory impairment in a transgenic mouse model of Alzheimer's disease.
Grossi C; Francese S; Casini A; Rosi MC; Luccarini I; Fiorentini A; Gabbiani C; Messori L; Moneti G; Casamenti F
J Alzheimers Dis; 2009; 17(2):423-40. PubMed ID: 19363260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
